The Carlyle Group Acquires Majority Stake in TriNetX

September 21, 2020

The Carlyle Group has made a strategic growth investment to acquire a majority stake in TriNetX, a global health research network that provides real-world clinical and claims data and analytics. Carlyle's investment will accelerate TriNetX's development of clinical research capabilities, support global expansion, and fund both organic and inorganic growth opportunities.

Targets
TriNetX
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.